Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme

@inproceedings{Kase2013ImpactOC,
  title={Impact of CD133 positive stem cell proportion on survival in patients with glioblastoma multiforme},
  author={Marju Kase and Ave Minajeva and Kristi Niinepuu and Sandra Kase and Markus Vardja and Toomas Asser and Jana Jaal},
  booktitle={Radiology and oncology},
  year={2013}
}
BACKGROUND The aim of the study was to assess the impact of CD133-positive (CD133+) cancer stem cell proportions on treatment results of glioblastoma multiforme (GBM) patients. PATIENTS AND METHODS Patients with GBM (n = 42) received postoperative radiotherapy (± chemotherapy). Surgically excised GBM tissue sections were immunohistochemically examined for CD133 expression. The proportions of CD133+ GBM cells were determined (%). The proportion of CD133+ GBM stem cells was established by 2… CONTINUE READING